Indutrade today signed an agreement to acquire all of the shares in Medexa
Diagnostisk Service AB, with annual sales of approximately SEK 25 million.
Medexa specialises in high-end technology for healthcare with a focus on foetal
surveillance and ultrasound applications. Customers consist primarily of county
councils and private clinics.
Indutrade takes possession of the company today, and it will be part of the
Industrial Components business area. The acquisition is expected to have a
marginally positive impact on Indutrade’s earnings per share.
Since 2008, annual sales in Indutrade’s medical technology segment have grown
from approximately SEK 60 million to approximately SEK 400 million.
Stockholm, 8 October 2013
INDUTRADE AB (publ)
For further information, please contact: Johnny Alvarsson, President and CEO:
+46 70 589 17 95
About Indutrade
Indutrade markets and sells components, systems and services with a high-tech
content within selected niches. Indutrade's business is distinguished by
- high-tech products for recurring needs
- growth through a structured and tried-and tested acquisition strategy
- a decentralised organisation characterised by an entrepreneurial spirit.
The Group is organised into five business areas: Engineering & Equipment, Flow
Technology, Fluids & Mechanical Solutions, Industrial Components and Special
Products. Indutrade's sales totalled SEK 8,384 million in 2012, generating
operating income of SEK 905 million before depreciation of intangible assets.
Indutrade is listed on the Nasdaq OMX Stockholm.
